Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check5 days agoChange DetectedThe study record no longer includes a MedlinePlus Genetics link associated with schizophrenia-related information.SummaryDifference0.1%

- Check12 days agoChange DetectedThe study record page changed from displaying a 403 Forbidden error to a “TypeError: Failed to fetch” message, and the NIH transition notice disappeared.SummaryDifference1%

- Check19 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide banner announces NIH website transition updates and notes that “Super Intelligence” is replacing “Artificial Intelligence” in some federal agency content.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.